Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -994 | -354 | -4,683 | -2,725 | -2,126 |
| Depreciation Amortization | 305 | 156 | 782 | 458 | 304 |
| Income taxes - deferred | 0 | N/A | 5 | 0 | 0 |
| Accounts receivable | -136 | -39 | 147 | 20 | -66 |
| Accounts payable and accrued liabilities | 207 | 251 | -122 | -23 | 166 |
| Other Working Capital | 210 | -439 | -278 | -551 | -722 |
| Other Operating Activity | 416 | -124 | 1,566 | 693 | 492 |
| Operating Cash Flow | $7 | $-548 | $-2,584 | $-2,128 | $-1,952 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 47 | -26 | -77 | -882 | -869 |
| Net Acquisitions | N/A | N/A | 166 | 166 | 165 |
| Other Investing Activity | 0 | 0 | -608 | 0 | 0 |
| Investing Cash Flow | $47 | $-26 | $-518 | $-717 | $-704 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 93 | 23 | -431 | -177 | -139 |
| Debt Issued | 280 | 0 | N/A | N/A | N/A |
| Debt Repayment | N/A | -3 | N/A | N/A | N/A |
| Common Stock Issued | 148 | 55 | 2,961 | 2,999 | 2,999 |
| Other Financing Activity | -769 | 335 | 370 | 0 | 0 |
| Financing Cash Flow | $-249 | $410 | $2,900 | $2,822 | $2,861 |
| Exchange Rate Effect | 9 | 0 | 0 | 114 | 115 |
| Beginning Cash Position | 825 | 825 | 1,027 | 1,027 | 1,027 |
| End Cash Position | 638 | 660 | 825 | 1,118 | 1,346 |
| Net Cash Flow | $-187 | $-165 | $-202 | $92 | $319 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7 | -548 | -2,584 | -2,128 | -1,952 |
| Capital Expenditure | 47 | -26 | -77 | -882 | -869 |
| Free Cash Flow | 54 | -575 | -2,660 | -3,010 | -2,822 |